Ling-Fan Xu

Ling-Fan Xu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
HXHuan Xu
Huan Xu
SLSangsang Li
Sangsang Li
YSYi Sun
Yi Sun
LXLing-Fan Xu
Ling-Fan Xu
XHXIN HONG
XIN HONG
HHHAILIANG HU
HAILIANG HU
Prostate cancer (PCa) exhibits an elevated level of de novo lipogenesis that provides both energy and basic metabolites for its malignant development. Long-chain polyunsaturated fatty acids (PUFAs) are elongated and desaturated from palmitate but their effects on PCa progression remain largely unknown. Here, we showed that PUFAs were significantly upregulated by androgen deprivation therapy (ADT) and elevated in neuroendocrine (NE)-like PCa cells. The key enzyme of PUFA elongation, ELOVL5, was overexpressed in NE-like PCa cells as well. Furthermore, we demonstrated that knocking down ELOVL5 in enzalutamide resistant NE-like PCa cells diminished the neuroendocrine phenotypes and enzalutamide resistance, while overexpressing ELOVL5 augmented the enzalutamide resistance of PCa cells in vitro and in vivo. Mechanistically, ELOVL5-mediated PUFA elongation enhanced the lipid raft-associated AKT-mTOR signaling activation and therefore contributes to the enzalutamide resistance. These findings suggest that ELOLV5-mediated PUFA elongation may be a potential novel target for the treatment of enzalutamide resistant NE-like PCa.

11 September 2024 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
SYShao-Yu Yue
Shao-Yu Yue
WLWei-Yi Li
Wei-Yi Li
SXShun Xu
Shun Xu
XBXiao-Xin Bai
Xiao-Xin Bai
WXWen-Long Xu
Wen-Long Xu
CLChaozhao Liang
Chaozhao Liang
Background: The gut microbiota has been demonstrated to have a significant role in the pathogenesis and progression of a variety of diseases, including prostate cancer, prostatitis, and benign prostatic hyperplasia. Potential links between prostate diseases, immune cells and the gut microbiota have not been adequately investigated.Methods: MR studies were conducted to estimate the effects of instrumental variables obtained from genome-wide association studies (GWASs) of 196 gut microbial taxa and 731 immune cells on the risk of prostate diseases. The primary method for analysing causal relationships was inverse variance-weighted (IVW) analysis, and the MR results were validated through various sensitivity analyses.Results: MR analysis revealed that 28 gut microbiome taxa and 75 immune cell types were significantly associated with prostate diseases. Furthermore, reverse MR analysis did not support a causal relationship between prostate diseases and the intestinal microbiota or immune cells. Finally, the results of the mediation analysis indicated that Secreting Treg % CD4 Treg, Activated & resting Treg % CD4 Treg, and Mo MDSC AC inhibited the role of the class Mollicutes in reducing the risk of PCa. In prostatitis, CD8+ T cells on EM CD8br hinder the increased risk associated with the genus Eubacterium nodatum group. Interestingly, in BPH, CD28- CD25++CD8br AC and CD16-CD56 on HLA DR+ NK promoted the role of the genus Dorea in reducing the risk of BPH.Conclusion: This study highlights the complex relationships among the gut microbiota, immune cells and prostate diseases. The involvement of the gut microbiota in regulating immune cells to impact prostate diseases could provide novel methods and concepts for its therapy and management.

23 April 2024 in Asian Journal of Andrology
Verified
Journal Article
Open access
JWJing Wang
Jing Wang
HDHe-Kang Ding
He-Kang Ding
HXHan-Jiang Xu
Han-Jiang Xu
DHDe-Kai Hu
De-Kai Hu
WHWilliam Hankey
William Hankey
LXLing-Fan Xu
Ling-Fan Xu
Tumor metabolic reprogramming is a hallmark of cancer development, and targeting metabolic vulnerabilities has been proven to be an effective approach for castration-resistant prostate cancer (CRPC) treatment. Nevertheless, treatment failure inevitably occurs, largely due to cellular heterogeneity, which cannot be deciphered by traditional bulk sequencing techniques. By employing computational pipelines for single-cell RNA sequencing, we demonstrated that epithelial cells within the prostate are more metabolically active and plastic than stromal cells. Moreover, we identified that neuroendocrine (NE) cells tend to have high metabolic rates, which might explain the high demand for nutrients and energy exhibited by neuroendocrine prostate cancer (NEPC), one of the most lethal variants of prostate cancer (PCa). Additionally, we demonstrated through computational and experimental approaches that variation in mitochondrial activity is the greatest contributor to metabolic heterogeneity among both tumor cells and nontumor cells. These results establish a detailed metabolic landscape of PCa, highlight a potential mechanism of disease progression, and emphasize the importance of future studies on tumor heterogeneity and the tumor microenvironment from a metabolic perspective.

24 December 2024 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
ZCZiqi Chen
Ziqi Chen
HDHekang Ding
Hekang Ding
YZYunlong Zhu
Yunlong Zhu
SSShuai Sun
Shuai Sun
ZSZhenyu Song
Zhenyu Song
LXLing-Fan Xu
Ling-Fan Xu

26 September 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
MXMu-Yang Xu
Mu-Yang Xu
XWXu Wang
Xu Wang
SYShao-Yu Yue
Shao-Yu Yue
QMQing-Wei Meng
Qing-Wei Meng
XBXiao-Xin Bai
Xiao-Xin Bai
CLChaozhao Liang
Chaozhao Liang
The increased expression of hsa-miR-21-5p in clear cell renal cell carcinoma (ccRCC) patients is closely linked to poor overall survival. Our predictive model, validated through tumor grading and staging, corresponds with enrichment analysis results and is further supported by PCR findings. Target gene predictions highlight the role of calcium ion transport and basement membrane functionality, with links to critical signaling pathways like JAK-STAT, cGMP-PKG, and sphingolipid, which play crucial roles in biological processes. Patients with higher levels of hsa-miR-21-5p show reduced responses to immunotherapy. In contrast, drug sensitivity analysis reveals increased vulnerability to drugs such as axitinib, sunitinib, and cabozantinib. This extensive investigation reveals the molecular complexities of ccRCC and suggests potential therapeutic options. In conclusion, upregulation of hsa-miR-21-5p in ccRCC is closely associated with tumor initiation and progression, indicating a poor prognosis. Its impact on the tumor microenvironment impairs the efficacy of immune therapies, contributing to adverse prognostic outcomes.